On Monday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) was -8.04% drop from the session before settling in for the closing price of $16.55. A 52-week range for TNXP has been $6.76 – $69.97.
Annual sales at Healthcare sector company grew by 73.03% over the past five years. When this article was written, the company’s average yearly earnings per share was at 92.40%. With a float of $12.78 million, this company’s outstanding shares have now reached $12.79 million.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tonix Pharmaceuticals Holding Corp stocks. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.04%, while institutional ownership is 23.33%. The most recent insider transaction that took place on Aug 21 ’25, was worth 15,061. In this transaction Director of this company bought 418 shares at a rate of $36.03, taking the stock ownership to the 418 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Director bought 250 for $36.00, making the entire transaction worth $9,000. This insider now owns 250 shares in total.
Tonix Pharmaceuticals Holding Corp (TNXP) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 92.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 74.04% during the next five years compared to 73.03% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
You can see what Tonix Pharmaceuticals Holding Corp (TNXP) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -986.99, a number that is poised to hit -3.19 in the next quarter and is forecasted to reach -7.80 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) saw its 5-day average volume 0.72 million, a negative change from its year-to-date volume of 0.73 million. As of the previous 9 days, the stock’s Stochastic %D was 12.83%.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 2.70%, which indicates a significant increase from 0.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.02 in the past 14 days, which was lower than the 1.85 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.40, while its 200-day Moving Average is $27.03. Nevertheless, the first resistance level for the watch stands at $16.26 in the near term. At $17.29, the stock is likely to face the second major resistance level. The third major resistance level sits at $17.82. If the price goes on to break the first support level at $14.70, it is likely to go to the next support level at $14.17. The third support level lies at $13.14 if the price breaches the second support level.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
There are 12,173K outstanding shares of the company, which has a market capitalization of 194.63 million. As of now, sales total 10,090 K while income totals -130,040 K. Its latest quarter income was 3,290 K while its last quarter net income were -32,010 K.
